Jan 06, 2022 / 09:00PM GMT
Chris Cooper - Goldman Sachs Group, Inc., Research Division - Research Analyst
Okay. Welcome back, everyone to the 14th Annual Healthcare CEOs Unscripted Conference. For those that don't know me, my name is Chris Cooper. I'm the healthcare analyst here at Goldman Sachs in Australia. For the next session, we are very fortunate to be joined by Mick Farrell, the CEO of ResMed. In a moment, I'll invite Mick to make a couple of minutes of introductory comments about himself and the company.
And then after that, the format of the session is going to be very informal. It's unscripted. We will -- we have 60 minutes or so for the session. If you do have any specific questions you'd like us to cover during the course of the session, please just e-mail me directly, and I'll try my best to weave in those questions into the discussion as we go. My e-mail is [email protected]. And without further ado, I'll hand over to Mick for some introductory comments. Thanks very much.
Michael J. Farrell - ResMed Inc. - CEO & Director
Well, thanks, Chris, and great to be
Resmed Inc at Goldman Sachs Healthcare CEOs Unscripted Conference: A View from the Top (Virtual) Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers